Abstract P4-07-05: PARP inhibition in breast and ovarian patient-derived tumor xenografts (PDX) harboring germline BRCA1/2 mutations unveils mechanisms of primary and acquired resistance that restore homologous recombination (HR)
暂无分享,去创建一个
C. Caldas | J. Baselga | J. Cortes | M. O’Connor | J. Arribas | O. Díez | V. Serra | M. Castroviejo | I. Rubio | C. Cruz | A. Bruna | J. Balmaña | M. Palafox | L. Prudkin | B. Morancho | G. Caratù | Ld Bustos | A. Gris | A. Llop | S. Gutiérrez